Hospital-Level Variation and Predictive Model for Diagnosis of Transthyretin Amyloid Cardiomyopathy Among Patients Hospitalized for Heart Failure

By sjmartinez • April 1, 2025

Shoji S, Solomon N, Chiswell K, Selvaraj S, Khouri MG, Lewsey SC, Baylor L, Bruno M, Fonarow GC, Greene SJ. Hospital-Level Variation and Predictive Model for Diagnosis of Transthyretin Amyloid Cardiomyopathy Among Patients Hospitalized for Heart Failure. J Card Fail. 2025 Mar 26:S1071-9164(25)00150-2. doi: 10.1016/j.cardfail.2025.03.013. Epub ahead of print. PMID: 40164406.

Tags: Cardiology/Epi, Publications

Myeloid cell-specific Beta2-adrenergic receptor deletion improves early cardiac injury resolution via de-repression of Anxa1

Nayak TK, Bajpai A, Patwa V, Carter RL, Enjamuri N, Gao E, Rajan S, Xiang YK, Tilley DG. Myeloid cell-specific β2-adrenergic receptor deletion improves early[...]

Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisation

Oshima A, Serruys PW, Garg S, McEvoy JW, Wood DA, Doenst T, Taggart DP, Puskas JD, Shajahan A, Sharif F, Miyashita K, Tobe A, Tsai[...]

Five-Year Outcomes After Prostate-Specific Membrane Antigen PET/CT-Guided Salvage Radiotherapy Following Radical Prostatectomy

Nikitas J, Smith CP, Armstrong WR, Murthy V, Grogan T, Clark K, Moore J, Roberts M, Farolfi A, Reiter RE, Rettig MB, Shen J, Valle[...]